Sign In
Buy NHS
$6.34
-0.0500 (-0.782%)
At Close: Jun 03, 2026
NEUBERGER BERMAN HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION
04:30pm, Friday, 30'th May 2025
NEW YORK , May 30, 2025 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock
NHS: Double-Digit Yielding Bond Fund Suppressed By Higher Rates
03:06pm, Thursday, 29'th May 2025
NHS provides a high 14.7% yield by investing in below investment grade debt, but this comes with elevated risk and price volatility. The fund's NAV and price have steadily declined, reflecting sensiti
LONDON--(BUSINESS WIRE)--AviadoBio, a pioneering gene therapy company dedicated to developing and delivering potentially transformative medicines for neurodegenerative disorders, today announced that
NEUBERGER BERMAN HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION
04:30pm, Wednesday, 30'th Apr 2025
NEW YORK , April 30, 2025 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common sto
4 CEFs To Consider For Your High-Yield Income Compounder Portfolio
05:26am, Friday, 25'th Apr 2025
Heightened market volatility offers unique buying opportunities for income investors, particularly in high-yield income funds like CEFs and ETFs, ideal for retirement portfolios. CEFs are attractive d
NEUBERGER BERMAN HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION
04:30pm, Monday, 31'st Mar 2025
NEW YORK , March 31, 2025 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common sto
NHS: Hard To Justify Buying This Fund At The Current Price
10:22am, Thursday, 20'th Mar 2025
The Neuberger Berman High Yield Strategies Fund offers a 14.23% yield, significantly higher than major bond indices and its peers, raising concerns about sustainability. The NHS closed-end fund's high
NEUBERGER BERMAN HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION
09:29am, Monday, 03'rd Mar 2025
NEW YORK , March 3, 2025 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stoc
NEUBERGER BERMAN HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION
04:30pm, Friday, 31'st Jan 2025
NEW YORK , Jan. 31, 2025 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stoc
NEUBERGER BERMAN HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION
04:30pm, Tuesday, 31'st Dec 2024
NEW YORK , Dec. 31, 2024 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stoc
NHS: This Fund Underperforms Its Peers, And A Hawkish Fed Could Prove Problematic
11:14am, Monday, 23'rd Dec 2024
The Neuberger Berman High Yield Strategies offers a high yield of 14.42%, better than the domestic junk bond index but with higher volatility. Despite its high yield, the market doubts the fund's abil
Lilly obesity drug Mounjaro to be offered in Britain's NHS after watchdog nod
10:41am, Monday, 23'rd Dec 2024
Eli Lilly's obesity drug Mounjaro will be available through Britain's state health system for some patients from March, after the drugs cost-effectiveness watchdog NICE on Monday gave its blessing.
LONDON, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialisation of novel therapies for rare and ul
Kings College NHS Trust Selects Blink Charging to Install 41 EV Chargers at Orpington's Princess Royal University Hospital
07:00am, Thursday, 12'th Dec 2024
London, UK, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Blink Charging UK (“Blink UK”), a subsidiary of Blink Holdings BV, a wholly owned subsidiary of Blink Charging Co., a leading global manufacturer, own
Mounjaro searches soar after NHS go-ahead
07:35am, Monday, 09'th Dec 2024
Online searches for Eli Lilly and Co's (NYSE:LLY) weight loss and diabetes drug Mounjaro have soared more than four-fold since the NHS received approval for weight loss programmes last week. UK drug
